Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
749
-
Total shares
-
273M
-
Shares change
-
+29.6M
-
Total reported value, excl. options
-
$9.67B
-
Value change
-
+$1.02B
-
Put/Call ratio
-
1.01
-
Number of buys
-
219
-
Number of sells
-
-448
-
Price
-
$35.47
Significant Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q4 2017
773 filings reported holding GSK - GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM as of Q4 2017.
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) has 749 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 273M shares
.
Largest 10 shareholders include DODGE & COX (44.1M shares), ROYAL BANK OF CANADA (25.5M shares), FMR LLC (19.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (16.6M shares), Fisher Asset Management, LLC (12.8M shares), STATE STREET CORP (10.3M shares), RENAISSANCE TECHNOLOGIES LLC (9.67M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8.41M shares), WELLS FARGO & COMPANY/MN (7.16M shares), and BANK OF AMERICA CORP /DE/ (6.75M shares).
This table shows the top 749 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.